FDA Law Blog
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. those reviewed by the CDER Division of Rare Diseases and Medical Genetics). By Sarah Wicks & James E. Valentine & Frank J.
ABIM
JUNE 4, 2025
In 2024, 77% of eligible ABIM Board Certified endocrinologists who chose an assessment opted for the LKA over the traditional, 10-year MOC exam. Special Consideration IMG Pilot Pathway* In August 2024 , the ABIM Council proposed a pilot model for exceptionally qualified IMGs pursuing accredited subspecialty fellowship in the U.S.
ABIM
JUNE 11, 2025
This is now being reviewed by the American Board of Medical Specialties, which oversees ABIM. In 2024, 75% of infectious disease physicians who chose an assessment opted for the LKA over the traditional, 10-year MOC exam.
Expert insights. Personalized for you.
105 
Let's personalize your content